Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile | table of contents
Premium Company Profile Novavax (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 31/10/2007
- Report Title: Premium Company Profile Novavax
- View Report Summary: View Report Summary
- Report Type: Company Profile
- Country: Global
- Number of Pages: 46
TABLE OF CONTENTS
Overview 1
Catalyst 1
Summary 1
Company Structure 7
Company Overview and Key Facts 7
Business Description 8
History 10
Company Financials 12
Stock Market Performance 12
P&L 13
Balance Sheet 16
Cash Flow 16
Business Segment Performance 17
Products & Services 19
Marketed Products 19
Pipeline Products 20
AC Forecast Product Sales 21
Competitors and Strategic Business Relationships 23
Key Competitors 23
Key Suppliers 23
Key Clients 24
Shareholding Structure 25
Strategy 26
Company View 26
Corporate Strategy 26
SWOT Analysis 28
Overview 28
Strengths 29
Weaknesses 30
Opportunities 31
Threats 32
Value Chain Analysis 33
Overview 33
Discovery and Product Development 33
Manufacturing 34
Scorecard 35
Overview 35
Scorecard Analysis 36
Key Employees 37
List of Key Employees 37
Key Employee Biographies 38
Financial and Operational Overview 42
Financial and Operational Overview 42
Key Industry Specific Ratios 44
APPENDIX 45
Ask the analyst 45
Datamonitor consulting 45
Disclaimer 45
TABLE OF FIGURES
Figure 1: Novavax - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
Figure 2: Novavax - Key Strategic Revenues, 2002-2006 ($ Mn) 18
Figure 2: Novavax - Key Strategic Revenues, 2006-2010 ($ Mn) 22
TABLE OF TABLES
Table 1: Novavax - Key Facts 7
Table 2: Novavax - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
Table 3: Novavax - Key Events Impacting Share Price Performance 12
Table 4: Novavax - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
Table 5: Novavax - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 15
Table 6: Novavax - Balance Sheet, 2002-2006 ($ Mn) 16
Table 7: Novavax - Cash Flow, 2002-2006 ($ Mn) 16
Table 8: Novavax - Revenue Breakdown by Division, 2002-2006 ($ Mn) 17
Table 9: Novavax - Marketed Products 19
Table 10: Novavax - Collaboration Products 20
Table 11: Novavax - Forecast Sales, 2006-2010 ($ Mn) 21
Table 12: Novavax - Key Competitors 23
Table 13: Novavax - Key Clients 24
Table 14: Novavax – Key Shareholders 25
Table 15: Novavax - SWOT Analysis Summary 28
Table 16: Novavax – Value Chain Analysis 33
Table 17: Novavax - Scorecard 35
Table 18: Novavax - Key Employees 37
Table 19: Novavax - Financial and Operational Overview 42
Table 20: Novavax - Key Industry Specific Ratios 44
Overview 1
Catalyst 1
Summary 1
Company Structure 7
Company Overview and Key Facts 7
Business Description 8
History 10
Company Financials 12
Stock Market Performance 12
P&L 13
Balance Sheet 16
Cash Flow 16
Business Segment Performance 17
Products & Services 19
Marketed Products 19
Pipeline Products 20
AC Forecast Product Sales 21
Competitors and Strategic Business Relationships 23
Key Competitors 23
Key Suppliers 23
Key Clients 24
Shareholding Structure 25
Strategy 26
Company View 26
Corporate Strategy 26
SWOT Analysis 28
Overview 28
Strengths 29
Weaknesses 30
Opportunities 31
Threats 32
Value Chain Analysis 33
Overview 33
Discovery and Product Development 33
Manufacturing 34
Scorecard 35
Overview 35
Scorecard Analysis 36
Key Employees 37
List of Key Employees 37
Key Employee Biographies 38
Financial and Operational Overview 42
Financial and Operational Overview 42
Key Industry Specific Ratios 44
APPENDIX 45
Ask the analyst 45
Datamonitor consulting 45
Disclaimer 45
TABLE OF FIGURES
Figure 1: Novavax - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
Figure 2: Novavax - Key Strategic Revenues, 2002-2006 ($ Mn) 18
Figure 2: Novavax - Key Strategic Revenues, 2006-2010 ($ Mn) 22
TABLE OF TABLES
Table 1: Novavax - Key Facts 7
Table 2: Novavax - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
Table 3: Novavax - Key Events Impacting Share Price Performance 12
Table 4: Novavax - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
Table 5: Novavax - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 15
Table 6: Novavax - Balance Sheet, 2002-2006 ($ Mn) 16
Table 7: Novavax - Cash Flow, 2002-2006 ($ Mn) 16
Table 8: Novavax - Revenue Breakdown by Division, 2002-2006 ($ Mn) 17
Table 9: Novavax - Marketed Products 19
Table 10: Novavax - Collaboration Products 20
Table 11: Novavax - Forecast Sales, 2006-2010 ($ Mn) 21
Table 12: Novavax - Key Competitors 23
Table 13: Novavax - Key Clients 24
Table 14: Novavax – Key Shareholders 25
Table 15: Novavax - SWOT Analysis Summary 28
Table 16: Novavax – Value Chain Analysis 33
Table 17: Novavax - Scorecard 35
Table 18: Novavax - Key Employees 37
Table 19: Novavax - Financial and Operational Overview 42
Table 20: Novavax - Key Industry Specific Ratios 44
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
